Topical Foam May Extend Remission From Plaque Psoriasis

The efficacy of twice-weekly, fixed-dose combination calcipotriene 0.005%/betamethasone dipropionate 0.064% (Cal/BD) foam for the long-term maintenance of plaque psoriasis was supported in results from a clinical trial published in the Journal of the American Academy of Dermatology.

Compared with patients who received placebo, those who used Cal/BD were more likely to remain in remission during 1 year of follow-up. The foam was well-tolerated, with few serious adverse events reported.

Read the full article at

Source link

Related posts

CoolSculpting for the Summer Season


Rasch Analysis of the Patient and Observer Scar Assessment Scale in Linear Scars: Suggestions for a Patient and Observer Scar Assessment Scale v2.1


How Long For The Swelling To Go Down After A Sliding Genioplasty?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy